Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Thromboembolic Complications clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Thromboembolic Complications: 1 US clinical trial tracked, none currently recruiting.

Thromboembolic Complications is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Oregon Health and Science University, running 1 of these trials.

Enrollment posture brief

Registry condition thromboembolic-complications

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Thromboembolic Complicat (th…0%
Open-enrollment share among volume-matched conditions near Thromboembolic Complications

Thromboembolic Complications has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Thromboembolic Complications on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Thromboembolic Complications is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Thromboembolic Complications records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Enoxaparin 30 mg BID Drug
1 trials
Enoxaparin dose adjusted Lovenox based on TEG Drug
1 trials

US sites by state

Facility locations filed on Thromboembolic Complications trials. A trial with sites in several states counts in each.

Washington 1 trials
Texas 1 trials
Oregon 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Thromboembolic Complications page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Thromboembolic Complications trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Oregon Health and Science University sponsors the most Thromboembolic Complications trials on record, review their full trial history before evaluating a specific study. See Oregon Health and Science University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Thromboembolic Complications condition card totals 1 registered trials; most-linked intervention Enoxaparin 30 mg BID; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.